Literature DB >> 11988509

Enteropathogenic Escherichia coli translocate Tir and form an intimin-Tir intimate attachment to red blood cell membranes.

Robert K Shaw1, Sarah Daniell, Gad Frankel, Stuart Knutton.   

Abstract

Type III secretion allows bacteria to inject effector proteins into host cells. In enteropathogenic Escherichia coli (EPEC) the type III secreted protein, Tir, is translocated to the host-cell plasma membrane where it functions as a receptor for the bacterial adhesin intimin, leading to intimate bacterial attachment and "attaching and effacing" (A/E) lesion formation. To study EPEC type III secretion the interaction of EPEC with monolayers of red blood cells (RBCs) has been exploited and in a recent study [Shaw, R. K., Daniell, S., Ebel, F., Frankel, G. & Knutton, S. (2001 ). Cell Microbiol 3, 213-222] it was shown that EPEC induced haemolysis of RBCs and translocation of EspD, a putative pore-forming type III secreted protein in the RBC membrane. Here it is demonstrated that EPEC are able to translocate and correctly insert Tir into the RBC membrane and produce an intimin-Tir intimate bacterial attachment, identical to that seen in A/E lesions. Following translocation Tir did not undergo any change in apparent molecular mass or become tyrosine-phosphorylated and there was no focusing of RBC cytoskeletal actin beneath intimately adherent bacteria, and no pedestal formation. This study, employing an RBC model of infection, has demonstrated that Tir translocation can be separated from host-cell-mediated Tir modifications; the data show that the EPEC type III protein translocation apparatus is sufficient to deliver and correctly insert Tir into host-cell membranes independent of eukaryotic cell functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988509     DOI: 10.1099/00221287-148-5-1355

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  14 in total

Review 1.  Virulence of enteropathogenic Escherichia coli, a global pathogen.

Authors:  S C Clarke; R D Haigh; P P E Freestone; P H Williams
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

2.  Transcriptome of enterohemorrhagic Escherichia coli O157 adhering to eukaryotic plasma membranes.

Authors:  Sivan Dahan; Stuart Knutton; Robert K Shaw; Valerie F Crepin; Gordon Dougan; Gad Frankel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

3.  Atypical Enteropathogenic Escherichia coli: from Kittens to Humans and Beyond!

Authors:  Shantanu Bhatt
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

4.  Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule.

Authors:  Yulia Shifrin; Adi Peleg; Ophir Ilan; Chen Nadler; Simi Kobi; Kobi Baruch; Gal Yerushalmi; Tatiana Berdichevsky; Shoshy Altuvia; Maya Elgrably-Weiss; Cecilia Abe; Stuart Knutton; Chihiro Sasakawa; Jennifer M Ritchie; Matthew K Waldor; Ilan Rosenshine
Journal:  J Bacteriol       Date:  2008-05-23       Impact factor: 3.490

5.  The N-terminal amphipathic region of the Escherichia coli type III secretion system protein EspD is required for membrane insertion and function.

Authors:  Dayal Dasanayake; Manon Richaud; Normand Cyr; Celia Caballero-Franco; Sabrina Pittroff; Ron M Finn; Juan Ausió; Wensheng Luo; Michael S Donnenberg; Armando Jardim
Journal:  Mol Microbiol       Date:  2011-06-28       Impact factor: 3.501

6.  Analysis of the function of enteropathogenic Escherichia coli EspB by random mutagenesis.

Authors:  Wensheng Luo; Michael S Donnenberg
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Pore-forming Activity of the Escherichia coli Type III Secretion System Protein EspD.

Authors:  Abhishek Chatterjee; Celia Caballero-Franco; Dannika Bakker; Stephanie Totten; Armando Jardim
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

Review 8.  The Evasive Enemy: Insights into the Virulence and Epidemiology of the Emerging Attaching and Effacing Pathogen Escherichia albertii.

Authors:  Shantanu Bhatt; Marisa Egan; Brian Critelli; Andrew Kouse; Daniel Kalman; Chirag Upreti
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

9.  The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors.

Authors:  Marie-Hélène Ruchaud-Sparagano; Sabrina Mühlen; Paul Dean; Brendan Kenny
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

10.  Cytosolic extract induces Tir translocation and pedestals in EPEC-infected red blood cells.

Authors:  Alyson I Swimm; Daniel Kalman
Journal:  PLoS Pathog       Date:  2008-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.